Details

Autor(en) / Beteiligte

• Tan, Mürşide
• Korkmaz, Hakan
• Aydın, Hüseyin
• Kumbul Doğuç, Duygu

Titel

FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis

Ist Teil von

• Turkish journal of medical sciences, 2019-10, Vol.49 (5), p.1490-1497

Ort / Verlag

Turkey: The Scientific and Technological Research Council of Turkey

Erscheinungsjahr

2019

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• The aim of this study is to evaluate the relationship between serum fatty acid binding protein 4 (FABP4) levels and carotid intima media thickness (CIMT) in patients with hypothyroidism. Forty subclinical hypothyroidism patients, 40 overt hypothyroidism patients, and 40 healthy controls were enrolled in the study. Blood pressure, body mass index, CIMT, fasting blood sugar, creatine, alanine aminotransferase, lipid parameters, insulin, free thyroxine, triiodothyronine, thyroid-stimulating hormone (TSH), thyroid peroxidase antibody (anti-TPO), thyroglobulin antibody (anti-TG), high-sensitivity C-reactive protein (Hs-CRP), and FABP4 levels of all participants were measured. Serum FABP4 levels were significantly higher in patients with subclinical and overt hypothyroidism than healthy controls (HCs) (P = 0.044 and P = 0.014, respectively). There was no significant difference in terms of FABP4 levels between patients with subclinical and overt hypothyroidism (P = 0.641). Serum TSH levels and serum FABP4 levels were positively correlated (r = 0.201, P = 0.039). CIMT was found to be higher in patients with subclinical and overt hypothyroidism than in HCs (P = 0.042 and P < 0.001, respectively). No correlation was found between CIMT and FABP4 levels (r = 0.038, P = 0.702). There was a positive correlation between CIMT and TSH, anti-TPO, anti-TG, triglycerides (TG), and total cholesterol levels. It was found that high TG levels were an independent factor that increased CIMT (r = 0.382, r2 = 0.146). In patients with subclinical and overt hypothyroidism, the level of FABP4 increases and this increase is correlated with the increase in TSH level. It is thought that FABP4 does not play a role in atherosclerosis development in patients with hypothyroidism without metabolic disorder.